Samira Abdeljalil Elfassi  <br/><br/>
Intravitreal versus posterior subtenon  injection of triamcinolone acetonide for treatment of diabetic macular edema /  
 المقارنة بين حقن الجسم الزجاجي وحقن غمد المقلة (خلف لفافة تينون) بمادة الترايامسينولون لعلاج الارتشاح السكري لمركز الابصار 
Samira Abdeljalil Elfassi ; Supervised Hany Salah Eldin Hamza , Ramy Riad Fekry , Dina Hossam Eldin Hassanin 
 - Cairo :   Samira Abdeljalil Elfassi ,   2015 
 - 101 P. :   charts , facsimiles ;   25cm 
<br/><br/>Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Ophthalmology 
<br/><br/> Currently there are many treatment modalities and strategies for DME. Many recent clinical studies show that intravitreal injection of the corticosteroid Triamcinolone Acetonide (TAA) reduce edematous retinal swelling and improve visual acuity in patients with DME. The objective of our prospective comparative study, which included 30 eyes randomized into two groups, was to assess the efficacy and safety of the posterior subtenon injection of Triamcinolone Acetonide  as compared to intravitreal injection for the treatment of diabetic macular edema. The results showed similar improvements in visual acuity and  significant decrease in central macular thickness (CMT) in both groups throughout the 3 months follow up period. However the IOP in the intravitreal injection group was significantly higher than in the posterior  subtenon injection group at 1 and 3 months after injection         
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>Diabetic Macular Edema Triamcinolone    Versus posterior subtenon